Organogenesis Holdings Inc. (ORGO) stock
ORGONasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.80−0.01 (-0.86%)
Close on Nov 16, 2026Market cap $103.34MP/E –Yield –
Organogenesis enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Organogenesis's enterprise value was $89.01M on Nov 11, 2026, against $593.03M a year earlier. Over the last 5 years it ranged from $52.74M to $1.09B, with a median of $328.06M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $89.01M | -85.0% |
| 2025 | Dec 31, 2025 | $593.03M | +80.1% |
| 2024 | Dec 31, 2024 | $329.32M | -24.9% |
| 2023 | Dec 29, 2023 | $438.24M | +79.5% |
| 2022 | Dec 30, 2022 | $244.14M | -77.5% |
| 2021 | Dec 31, 2021 | $1.09B | +40.6% |
| 2020 | Dec 31, 2020 | $772.27M | +78.5% |
| 2019 | Dec 31, 2019 | $432.55M | -32.9% |
| 2018 | Dec 31, 2018 | $644.78M | +27.5% |
| 2017 | Dec 29, 2017 | $505.60M | – |
See a number that looks wrong?